Blog Pharmaceutical Companies Pharmaceutical Manufacturing 
FDA Law Blog: Biosimilars
MARCH 6, 2024
FDA Law Blog readers can use discount code S10-866-866L24.S His practice supports clients throughout the life sciences from biotech startups and multinational pharmaceutical companies to CROs and academic researchers to patient advocacy organizations. More information about the conference can be found here.
Express Pharma
JUNE 1, 2024
Pharmaceutical companies face unique challenges due to their rapid digital transformation, adopting Internet of Things (IoT), Artificial Intelligence (AI), and blockchain technologies. Cybersecurity Challenges Intellectual Property Theft: Pharmaceutical companies invest heavily in research and development. With over 1.9
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
OCTOBER 27, 2022
The Guidance applies to all member companies of EFPIA and IFPMA, but also acts as useful guidance for all pharmaceutical companies as to how the authorities will interpret the legislative provisions to social media channels. However, the involvement of the company should always be stated.
PharmaState Academy
NOVEMBER 16, 2023
This blog delves into the key insights and perspectives from renowned veterans at The Now & Next Summit in Pharma Marketing 2023. ” The first panel at the Now & Next Summit featured prominent figures from top pharmaceutical companies. .”
Quality Matters
SEPTEMBER 15, 2023
PCM not ideal for every drug Continuous manufacturing “may not be fit for every pharmaceutical manufacturing process, but it can bring some advantages in some cases” compared with traditional batch manufacturing, summarized FDA’s Adam Fisher, Ph.D., See related Quality Matters blog on regulatory considerations.
Pharma Marketing Network
JUNE 11, 2020
RJ Lewis (EHS): So today everybody’s a publisher, part of the beauty of the web and even if you don’t have the technical skills for firing up a website or a blog, which is pretty easy. So whether you’re an advertiser or an event coordinator or a supplier in the industry, most of them have pretty active blogs.
HealthPartners
MAY 5, 2021
They may keep or pass through a percentage of prescription drug rebates paid by pharmaceutical companies in return for placing their drugs on the plan’s formulary (list of preferred drugs). Other drug sales-related incentive payments from drug manufacturers to the PBM may not be disclosed or passed through.
Expert insights. Personalized for you.
59 
Let's personalize your content